Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
for
Breast Carcinoma
Location: Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT02610413
Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 70+
Code: NCT04333706
Phase1, Phase2, Recruiting
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
for
Genetic Testing, BRCA1/2
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 25+
Code: NCT03396341
Recruiting
Cancer Pain Management Using a Web-based Intervention
for
Cancer of Breast, Depressive Symptoms, Cancer Pain
Location: Austin TX
Sponsor: University of Texas at Austin
Sex: Female
Age: 18+
Code: NCT06085313
Recruiting
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
for
Breast Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18 - 70+
Code: NCT06274034
Early_phase1, Recruiting
Interested in new breast cancer trials?
Get alerts for new trials in your area by subscribing now
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
for
Breast Carcinoma, Head and Neck Cancer, Lung Cancer
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 21+
Code: NCT05787834
Recruiting
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome